Northpond Ventures, LP 4
4 · DICE Therapeutics, Inc. · Filed Sep 20, 2021
Insider Transaction Report
Form 4
Northpond Ventures GP, LLC
10% Owner
Transactions
- Conversion
Common Stock
2021-09-17+2,603,075→ 2,603,075 total(indirect: By: Northpond Ventures, LP) - Conversion
Series B Convertible Preferred Stock
2021-09-17−1,735,388→ 0 total(indirect: By: Northpond Ventures, LP)→ Common Stock (1,735,388 underlying) - Conversion
Common Stock
2021-09-17+454,796→ 3,057,871 total(indirect: By: Northpond Ventures II, LP) - Conversion
Series C Convertible Preferred Stock
2021-09-17−867,687→ 0 total(indirect: By: Northpond Ventures, LP)→ Common Stock (867,687 underlying) - Purchase
Common Stock
2021-09-17$17.00/sh+235,000$3,995,000→ 3,292,871 total(indirect: By: Northpond Ventures II, LP) - Conversion
Series C-1 Convertible Preferred Stock
2021-09-17−454,796→ 0 total(indirect: By: Northpond Ventures II, LP)→ Common Stock (454,796 underlying)
Footnotes (4)
- [F1]Immediately prior to the closing of the initial public offering of DICE Therapeutics, Inc. (the "Issuer"), each share of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Convertible Preferred Stock"), of the Issuer and each share of Series C Convertible Preferred stock, par value $0.0001 per share of the Issuer (the "Series C Convertible Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). The right to convert the Series B Convertible Preferred Stock and Series C Preferred Stock into Common Stock had no expiration date.
- [F2]Immediately prior to the closing of the initial public offering of the Issuer, each share of Series C-1 Convertible Preferred Stock, par value $0.0001 per share (the "Series C-1 Convertible Preferred Stock"), of the Issuer automatically converted on a one-for-one basis into shares of the Issuer's Common Stock. The right to convert the Series C-1 Convertible Preferred Stock had no expiration date.
- [F3]Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- [F4]Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.